Poultry vaccines play a crucial role in maintaining the health and productivity of poultry flocks, including chickens, turkeys, ducks, and other birds raised for meat and egg production. These vaccines are designed to prevent or control various infectious diseases that can significantly impact the poultry industry. Common poultry vaccines target diseases such as Newcastle disease, infectious bronchitis, infectious bursal disease, avian influenza, Marek's disease, and fowl pox. These vaccines can be administered through different routes, including drinking water, spray, injection, or in ovo vaccination during the incubation period. Vaccination strategies vary based on the type of poultry, production system, and regional disease prevalence. Proper vaccination programs help reduce mortality, improve flock performance, and contribute to food safety by preventing the spread of zoonotic diseases. Continuous research in poultry vaccinology aims to develop more effective and cost-efficient vaccines, address emerging diseases, and enhance vaccination protocols to meet the evolving challenges faced by the global poultry industry.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States